9.5153

2.19% 0.2553

Applied Therapeutics Inc (APLT)

Overview News Price History Option Chain Financials Discussions Forecast

Applied Therapeutics Inc stock is traded at $9.5153, with a volume of 1.36M. It is up +2.19% in the last 24 hours and up +22.89% over the past month. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Previous Close:

$9.26

Open:

$9.32

24h Volume:

1.36M

Relative Volume:

0.57

Market Cap:

$1.10B

Revenue:

Net Income/Loss:

$-119.76M

P/E Ratio:

-8.5723

EPS:

-1.11

Net Cash Flow:

$-55.17M

1W Performance:

+8.14%

1M Performance:

+22.89%

6M Performance:

+98.79%

1Y Performance:

+299.26%

1-Day Range:

$9.00

$9.65

1-Week Range:

$8.383

$9.65

52-Week Range:

$1.79

$9.65

Applied Therapeutics Inc Stock (APLT) Company Profile

Name

Applied Therapeutics Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

212-220-9226

Address

545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY

Employee

Twitter

@Applied_Tx

Next Earnings Date

2024-11-07

Latest SEC Filings

APLT's Discussions on Twitter

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-04-22	Downgrade	Barclays	Overweight → Equal Weight
Aug-27-21	Downgrade	Goldman	Neutral → Sell
Jun-25-21	Resumed	Goldman	Neutral
Oct-08-20	Initiated	Truist	Buy
Apr-22-20	Initiated	Goldman	Buy
Feb-27-20	Initiated	Barclays	Overweight
Jun-10-19	Initiated	Citigroup	Buy
Jun-10-19	Initiated	Cowen	Outperform
Jun-10-19	Initiated	Robert W. Baird	Outperform

View All

Applied Therapeutics Inc Stock (APLT) Latest News

07:07 AM

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference - GlobeNewswire

07:07 AM

Nov 04, 2024

Applied Therapeutics (NASDAQ:APLT) Sets New 12-Month HighHere's Why - MarketBeat

Nov 04, 2024

Applied Therapeutics stock hits 52-week high at $9.41 - Investing.com

Nov 04, 2024

Applied Therapeutics stock hits 52-week high at $9.41 By Investing.com - Investing.com UK

Nov 04, 2024

Oct 31, 2024

US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels - Citeline

Oct 31, 2024

Oct 30, 2024

Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Oct 29, 2024

Trigg Minerals Announces Key AGM Resolutions - MSN

Oct 29, 2024

Oct 28, 2024

Trading (APLT) With Integrated Risk Controls - Stock Traders Daily

Oct 28, 2024

Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat

Oct 28, 2024

OncoSil Medical Plans Major Stock Issuance - MSN

Oct 28, 2024

Oct 27, 2024

Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World

Oct 27, 2024

Oct 26, 2024

Hennion & Walsh Asset Management Inc. Has $2.26 Million Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

Oct 26, 2024

Oct 25, 2024

Applied Therapeutics (NASDAQ:APLT) Shares Down 4.9%Here's What Happened - MarketBeat

Oct 25, 2024

William Blair Issues Pessimistic Outlook for APLT Earnings - Defense World

Oct 25, 2024

Oct 24, 2024

Q2 EPS Estimate for Applied Therapeutics Cut by Analyst - MarketBeat

Oct 24, 2024

Oct 23, 2024

Sharps Technology files to sell 259,092 shares of common stock for holders - MSN

Oct 23, 2024

Ardmore Shipping leads tanker stocks lower as Stifel downgrades, seeing softer rates - MSN

Oct 23, 2024

Invesco BulletShares 2024 High Yield Corporate Bond ETF declares monthly distribution of $0.1100 - MSN

Oct 23, 2024

Is the Options Market Predicting a Spike in American Healthcare REIT, Inc. (AHR) Stock? - MSN

Oct 23, 2024

Oct 22, 2024

Waste Connections Q3 2024 Earnings Preview - MSN

Oct 22, 2024

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA - MSN

Oct 22, 2024

Oct 21, 2024

Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings? - MSN

Oct 21, 2024

Oct 19, 2024

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - MSN

Oct 19, 2024

Oct 17, 2024

Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $12.50 - Defense World

Oct 17, 2024

Oct 16, 2024

Applied Therapeutics (NASDAQ:APLT) Trading Down 2.2%Here's What Happened - MarketBeat

Oct 16, 2024

There is no doubt that Applied Therapeutics Inc (APLT) ticks all the boxes. - SETE News

Oct 16, 2024

Applied Therapeutics Inc’s Market Journey: Closing Strong at 9.14, Up 2.81 - The Dwinnex

Oct 16, 2024

Oct 15, 2024

Varonis Systems Inc [VRNS] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024